Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000714 |
---|---|
Receipt number | R000000849 |
Scientific Title | A feasibility test on a postoperative Docetaxel plus TS-1 therapy for the patients with stage IIIA or stage IIIB gastric cancer (OGSG-0604) |
Date of disclosure of the study information | 2007/05/17 |
Last modified on | 2022/11/06 14:37:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/05/10 14:19:18 | ||
2 | Update | 2007/05/17 14:16:01 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Address Address TEL |
|
3 | Update | 2007/05/17 14:48:01 | Organization |
|
4 | Update | 2007/05/17 15:49:52 | Organization Organization |
|
5 | Update | 2007/08/23 14:01:29 | Recruitment status |
|
6 | Update | 2007/08/23 14:25:50 | Recruitment status |
|
7 | Update | 2008/11/06 17:15:59 | Recruitment status |
|
8 | Update | 2009/04/30 18:21:48 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2012/06/24 23:18:35 | Public title Public title Acronym Acronym |
|
10 | Update | 2012/06/24 23:28:39 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Tel1 Email1 |
|
11 | Update | 2012/06/24 23:33:25 | Last name of contact person |
|
12 | Update | 2012/06/24 23:37:46 | Division name Name of person sending information |
|
13 | Update | 2012/06/24 23:51:02 | Organization Organization |
|
14 | Update | 2017/02/12 23:50:29 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded URL releasing protocol Publication of results |
|
15 | Update | 2018/07/16 17:57:17 | URL releasing protocol URL related to results and publications |
|
16 | Update | 2022/11/06 14:18:22 | Date of IRB |
|
17 | Update | 2022/11/06 14:37:43 | URL releasing protocol Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |